UKCPA Webinar Number 2 – Critical Care Update

Critical Care Pharmacy Q&A – Tuesday 31 March | 7pm – 8pm

UKCPA Critical Care Committee Experts Greg Barton, Specialist Pharmacist, Critical Care and Burns, Mark Borthwick, Consultant Pharmacist Critical Care, David Sapsford, Consultant Pharmacist Critical Care, Emma Boxall Senior Specialist Critical Care Pharmacist will be providing essential guidance and answering your questions on:

– Acute Respiratory Distress Syndrome

– Fluid Management in Critical Care

– Renal Replacement Therapy

Please note this webinar is aimed at those new to clinical care.

Register for the event via the link below:

https://events.rpharms.com/ereg/newreg.php?eventid=200203949&

PLEASE NOTE: The webinar will be recorded and available to view from Wednesday 1 April.  We will add a link to this in the ‘Useful Websites’ section of the website: https://www.bopa.org.uk/useful-websites/

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article